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Abstract
Background: Cerebral malaria is one of the most severe manifestations of Plasmodium falciparum malaria. The
sequestration of parasitized red blood cells (PRBCs) to brain microvascular endothelium has been shown to
contribute to the pathophysiology of cerebral malaria. Recent studies reported increased levels of von Willebrand
factor (VWF) and reduced activity of VWF-cleaving protease, ADAMTS13 (a disintegrin and metalloproteinase with a
thrombospondin type 1 motif, member 13), in patients with cerebral malaria.
Methods: Association of six single nucleotide polymorphisms (SNPs) of the ADAMTS13 gene with cerebral malaria
was examined in 708 Thai patients with P. falciparum malaria.
Results: Among six SNPs, the derived allele of a SNP located in intron 28, rs4962153-A, was significantly associated
with protection against cerebral malaria when 115 cerebral malaria patients were compared with 367 mild malaria
patients (Fisher’s exact P-value = 0.0057; OR = 0.27; 95% CI = 0.096-0.76). Significant association was also detected
between 115 cerebral malaria and 593 non-cerebral malaria (226 non-cerebral severe malaria and 367 mild malaria)
patients (Fisher’s exact P-value = 0.012; OR = 0.30; 95% CI = 0.11-0.83).
Conclusions: Excessive adhesion of PRBCs to the platelet-decorated ultra-large VWF (ULVWF) appears to enhance
the sequestration of PRBCs to cerebral microvascular endothelium. The genetic association observed in the present
study implies that the regulation of platelet-decorated ULVWF strings by ADAMTS13 may play a role in the
development of cerebral malaria.
Background
Malaria is a major cause of morbidity and mortality in
tropical countries. Approximately 250 million clinical
cases of malaria occur, resulting in almost 1 million
deaths each year. Cerebral malaria, one of the most ser-
ious complications of Plasmodium falciparum malaria
infection, is an important cause of death. The excessive
sequestration of parasitized red blood cells (PRBCs) to
brain microvascular endothelium has been suggested to
specifically contribute to the pathophysiology of cerebral
malaria [1], yet the pathogenesis of cerebral malaria
remains poorly understood.
It has been demonstrated that levels of von Willeb-
rand factor (VWF) are significantly increased in malaria
patients compared with non-malarial patients with fever
or control subjects [2]. Further studies confirmed release
of VWF after endothelial cell activation in patients with
falciparum malaria [3-5] and detected adhesion of
PRBCs to platelet-decorated ultra-large VWF (ULVWF)
strings [3]. The platelet-decorated strings are cleaved
and regulated by plasma protease ADAMTS13 (a disin-
tegrin and metalloproteinase with a thrombospondin
type 1 motif, member 13) [6,7]. Together with the pre-
sence of abnormal circulating ULVWF multimers, a sig-
nificant reduction in plasma ADAMTS13 function was
also observed in cerebral or severe malaria patients
compared to healthy controls [5]. These observations
suggest that decreased ADAMTS13 activity plays a cru-
cial role in the development of cerebral malaria.
The human ADAMTS13 gene (OMIM *604134), span-
ning approximately 45 kb, is located on chromosome
9q34 [6,7]. To date, a number of ADAMTS13 mutations
causing congenital thrombotic thrombocytopaenic pur-
pura (TTP), a rare life-threatening disease characterized
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anaemia, renal failure, and neurological deficits includ-
ing coma, have been identified [6,8]. These symptoms
are also key features of severe falciparum malaria.
Although ADAMTS13 is a candidate gene for cerebral
malaria, no genetic association study of ADAMTS13 in
malaria patients has been conducted. This study reports
a significant association of common ADAMTS13 poly-
morphism with protection against cerebral malaria in
Thai patients with falciparum malaria.
Methods
Subjects
A total of 708 Thai patients infected with P. falciparum
living in north-west of Thailand, near the border with
Myanmar, were recruited in this study. Malarial infec-
tion by P. falciparum was confirmed by a positive blood
smear for the presence of asexual form of P. falciparum.
Clinical manifestations of malaria were classified accord-
ing to the definitions and associated criteria by the
World Health Organization. The mild malaria group
consisted of 367 patients with mild symptoms character-
ized by fever without other causes of infection and by
lack of the manifestations of severe malaria as described
below. The non-cerebral severe malaria group com-
prised 226 patients with severe malaria which was
defined as one with one of the following signs of sever-
ity or evidence of vital organ dysfunction: high parasi-
taemia (> 100,000 parasites/μL), hypoglycaemia (glucose
level < 22 nmol/L), severe anaemia (haematocrit < 20%
or haemoglobin level < 7 g/dL), a serum creatinine level
> 3.0 mg/dL. The cerebral malaria group consisted of
115 patients characterized by an unrousable coma and
exclusion of other causes of coma. The patients were
≥13 years old, and the average ages of the patients with
mild malaria, non-cerebral severe malaria and cerebral
malaria were 25.2, 20.5 and 28.6 years, respectively. All
patients underwent treatment at the Hospital for Tropi-
cal Disease, Faculty of Tropical Medicine, Mahidol Uni-
versity (Bangkok, Thailand). This study was approved by
the institutional review board of Faculty of Tropical
Medicine, Mahidol University, and the Research Ethics
Committee of the Graduate School of Comprehensive
Human Sciences, University of Tsukuba. Written
informed consent was obtained from every patient.
DNA extraction
Genomic DNA was extracted from peripheral blood leu-
kocytes using a QIAamp blood kit according to the
manufacturer’s instruction (QIAGEN, Hilden, Germany).
SNP selection
Based on the SNP genotype data of the Asian HapMap
samples, 45 Japanese in Tokyo, Japan (JPT) and 45 Han
Chinese in Beijing, China (CHB) [9,10], five SNPs with
minor allele frequency of more than 0.05 were selected
a st a gS N P sf r o m1 5S N P so ft h eADAMTS13 gene by
using the Tagger algorithm implemented in the Haplo-
view software version 4.2 with the default settings (i.e.,
pairwise tagging only with linkage disequilibrium (LD)
parameter, r
2, threshold of ≥ 0.8). Accordingly, five
SNPs were selected as tag SNPs (Table 1). In addition, a
synonymous SNP, rs1055432, was also selected since the
FastSNP Search, a web-based tool providing the poten-
tial functional effect of SNP, identified it as a SNP with
low-medium risk.
Genotyping
The TaqMan SNP Genotyping Assay was used to geno-
type six ADAMTS13 SNPs (Table 1) for 708 Thai
malaria patients using 7300 Real-Time PCR System
(Applied Biosystems). In this study, rs1055432 was gen-
otyped for the Asian HapMap samples (HapMap-JPT +
CHB) to investigate the LD structure of ADAMTS13.A
nonsynonymous SNP (rs11575933, P475S) located in
exon12 of ADAMTS13 was analysed in 128 Thai malaria
patients (64 from mild malaria group and 64 from cere-
bral malaria group) by using the polymerase chain reac-
tion (PCR)-direct sequencing. The PCR was performed
using the following primers: 5’-ACCCAGCTGGAGTT-
CATGTC-3’ and 5’-CCTATGACTCTGCCCTGTCC-3’,
and the PCR products were subjected to direct sequen-
cing with ABI prism 3100 Genetic Analyzer (Applied
Biosystems).
Statistical analyses
Deviation from Hardy-Weinberg equilibrium was tested
in each malaria group by chi-square test. The allele fre-
quency was compared between two malaria groups by
Fisher’s exact test. The odds ratio (OR) and 95% confi-
dence interval (CI) were calculated by Woolf’sm e t h o d .
In this study the direction of association was determined
based on the derived allele regardless of the allele fre-
quency. P-value ≤ 0.05 was considered statistically sig-
nificant. To address the problem of multiple testings,
permutation P-values were calculated for single SNPs
from 100,000 permutations using the Haploview soft-
ware, version 4.2. Haplotype frequency and pairwise LD
parameter, r
2, were estimated using the Haploview soft-
ware. The haplotype association test based on the per-
mutation procedure was conducted using the Haploview
software. In the haplotype association test, to find a hap-
lotype showing stronger association with cerebral
malaria than SNP, permutation P-values were calculated
for single SNPs and haplotypes from 100,000
permutations.
The association of rs4962153 with platelet count
obtained from 449 malaria patients before treatment
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Page 2 of 8(on Day 0) was assessed by analysis of covariance
(ANCOVA) adjusted for age (years), gender (female or
male), and symptom (mild, non-cerebral severe, or
cerebral), where dummy variables were used for
symptom.
Results
Association test
Six SNPs, two in exon and four in intron, of the
ADAMTS13 gene were analysed in this study (Table 1 and
Figure 1a). All the SNPs did not deviate from Hardy-
Table 1 SNPs analysed in this study
rs#
a HGVS name
a, b Chromosome coordinate
a Region
a Ancestral allele/derived allele
a (Allele frequency
c)
rs2301611 g.8488T >C 136290607 intron 3 T (0.854)/C (0.146)
rs3118667 g.8944C >T 136291063 exon 5 T (0.803)/C (0.197)
rs739469 g.16610G >C 136298729 intron 10 C (0.213)/G (0.787)
rs652600 g.28898G >A 136311017 intron 20 T (0.247)/C (0.753)
rs4962153 g.41635A >G 136323754 intron 28 G (0.921)/A (0.079)
rs1055432 g.42120C >A 136324239 exon 29 C (0.750
d)/A (0.250)
Note; HGVS (Human Genome Variation Society) name
a The SNP reference number, HGVS name, chromosome coordinate, region, and ancestral state were retrieved from the National Center for Biotechnology
Information (NCBI) SNP database build 132, September 2010.
b The position of SNP was determined according to the HGVS nomenclature based on the NCBI reference sequence NG_011934.1.
c The allele frequency in the Asian HapMap populations (JPT+CHB).
d The Asian HapMap samples were genotyped in this study.

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Figure 1 Structure of the ADAMTS13 gene and LD plot. A,A D A M T S 1 3p r o t e i n( 1 4 2 7a m i n oa c i d s) consisting of a signal peptide (S), a
propeptide (P), a metalloprotease domain (Met), a disintegrin-like domain (Dis), a thrombospondin type-1 (TSP-1) repeat (1), a cysteine-rich
domain (Cys), a spacer domain (Spa), seven additional TSP-1 repeats (2-8), and two complement C1r/C1s, Uegf, Bmp1 (CUB) domains. B,
ADAMTS13 gene comprising 29 exons on the human chromosome 9q34. C, LD plot among 15 SNPs with minor allele frequency of more than
0.05 in the Asian HapMap populations (JPT + CHB). Five tagSNPs and rs1055432 analysed in Thai malaria patients are indicated by arrows. A
pairwise r
2 value is shown in each square. Darker shading indicates higher r
2 value and black shading indicates r
2 of 1.
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Association analyses revealed that rs4962153-A
(derived allele of rs4962153) was strongly associated
with protection against cerebral malaria, when mild
and cerebral malaria groups were compared (Fisher’s
exact P-value = 0.0057; OR = 0.27; 95% CI = 0.096-
0.76; Table 2). The P-value was still significant even in
permutation test for six SNPs in the comparison
between mild and cerebral malaria groups (Permuta-
tion P-value = 0.041). There was no significant differ-
ence in allele frequency of rs4962153-A between non-
cerebral severe and cerebral malaria groups (P-value =
0.082), although a slight tendency towards protection
against cerebral malaria was observed in this compari-
son as well. When mild and severe malaria groups
were combined as a non-cerebral malaria group, the
frequency of rs4962153-A was significantly higher in
non-cerebral malaria than in cerebral malaria (Fisher’s
exact P-value = 0.012; OR = 0.30; 95% CI = 0.11-0.83),
while the permutation P-value was not significant.
The SNP rs11575933 (P475S) has been reported to
influence the proteolytic activity of ADAMTS13 [11-13].
In 128 Thai malaria patients, rs11575933-T (475S) allele
was not observed. Thus, the remaining samples were
not analysed, and rs11575933 was not considered in the
association analysis.
LD structure and haplotype frequency
The pairwise r
2 values among six ADAMTS13 SNPs
were not high in this study (Figure 2a). This is mainly
because they were selected as tag SNPs based on the
Asian HapMap populations (JPT + CHB). To evaluate
whether any ADAMTS13 haplotype consisting of six
ADAMTS13 SNPs shows stronger association with cere-
bral malaria than rs4962153, permutation P-values for
single SNPs and haplotypes were further calculated in
the comparison between mild and cerebral malaria
groups. In this setting, the permutation P-value of
rs4962153 was 0.080, and no haplotype showed permu-
tation P-value lower than rs4962153 (Figure 2b).
Table 2 Allele frequencies of ADAMTS13 SNPs in Thai malaria patients
SNP Allele frequency Association P-value
M (2n = 734) S (2n = 452) C (2n = 230) M vs C S vs C M + S vs C
a
rs2301611;
T 691 (0.94) 430 (0.95) 223 (0.97)
C 43 (0.06) 22 (0.05) 7 (0.03) 0.12 0.32 0.14
HWE P-value 0.23 0.44 0.74
rs3118667;
T 523 (0.71) 297 (0.66) 163 (0.71)
C 211 (0.29) 155 (0.34) 67(0.29) 0.93 0.19 0.64
HWE P-value 0.74 0.31 0.73
rs739469;
C 525 (0.72) 298 (0.66) 160 (0.70)
G 209 (0.28) 154 (0.34) 70 (0.30) 0.56 0.34 1.0
HWE P-value 0.41 0.26 0.88
rs652600;
T 470 (0.64) 273 (0.60) 152 (0.66)
C 264 (0.36) 179 (0.40) 78 (0.34) 0.58 0.16 0.33
HWE P-value 0.14 0.32 0.25
rs4962153;
G 689 (0.94) 431 (0.95) 226 (0.98)
A 45 (0.06) 21 (0.05) 4 (0.02) 0.0057
b 0.082 0.012
c
HWE P-value 0.14 0.44 0.84
rs1055432;
C 516 (0.70) 293 (0.65) 160 (0.70)
A 218 (0.30) 159 (0.35) 70 (0.30) 0.87 0.23 0.76
HWE P-value 0.16 0.76 0.55
Note; HWE, Hardy-Weinberg equilibrium; M, mild malaria; S, non-cerebral severe malaria; C, cerebral malaria.
a Since the frequency of rs4962153-A was different between mild and cerebral malaria groups, the frequency was further compared between non-cerebral (mild
and non-cerebral severe malaria groups) and cerebral malaria groups.
b OR = 0.27; 95% CI = 0.096-0.76; Permutation P-value = 0.041.
c OR = 0.30; 95% CI = 0.11-0.83; Permutation P-value = 0.074.
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H7 and H8 haplotypes (Figure 2b). The estimated fre-
quencies of these haplotypes in mild malaria patients
were higher than those in cerebral malaria patients, sug-
gesting that the significant association of rs4962153-A
with protection against cerebral malaria was not caused
by either one of the haplotypes bearing rs4962153-A.
Platelet counts and rs4962153
Since platelet-decorated ULVWF strings are cleaved and
regulated by ADAMTS13 [6,7], rs4962153 may influence
platelet counts in malaria patients. To evaluate this,
ANCOVA was conducted. The values adjusted for age,
gender, and symptom are shown in Figure 3. The result
indicated that platelet counts were not significantly
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Figure 2 LD plot and haplotype frequency in Thai malaria patients. A, LD plot among six SNPs analysed in 708 Thai malaria patients. A
pairwise r
2 value is shown in each square. Darker shading indicates higher r
2 value. B, Haplotype frequencies in mild and cerebral malaria
patients. Only haplotypes with frequency of more than 0.02 either in mild or in cerebral malaria patients are shown. Permutation P-values were
calculated for single SNPs and haplotypes from 100,000 permutations.
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rs4962153 (P-value = 0.98).
Discussion
The reduced activity of ADAMTS13 in malaria patients
may allow overproduction of ULVWF multimers. The
following adhesion of PBRCs to platelet-decorated
ULVWF strings would result in excessive sequestration
of PBRCs to brain microvascular endothelium. This has
been proposed as one of important mechanisms of
adhesion of PBRCs to endothelium in cerebral malaria
[14]. The present study revealed that rs4962153-A of
ADAMTS13 was significantly associated with protection
against cerebral malaria in 708 Thai malaria patients.
The genetic association observed in the present study
supports the above-mentioned role of ADAMTS13 in
the development of cerebral malaria, although the func-
tional significance of rs4962153-A remains to be stu-
died. A better understanding of the regulation of
platelet-decorated ULVWF strings by ADAMTS13
would provide new insights into the development of the
treatment of cerebral malaria. For instance, to eliminate
ULVWF and replace ADAMTS13, plasma exchange
might potentially be considered a new treatment.
Ap r e v i o u ss t u d yh a ss h o w nt h a tn o to n l yp l a s m a
ADAMTS13 activity but also plasma ADAMTS13 con-
centration were reduced in cerebral or severe malaria
patients compared to healthy controls [5]. Since the
frequency of rs4962153-A was higher in mild malaria
patients than in cerebral malaria patients, rs4962153-A
may enhance the plasma level of ADAMTS13, although
platelet counts were not affected by rs4962153-A (Figure
3). A recent study reported that rs4962153-A was signif-
icantly associated with susceptibility to ischemic stroke
in Swedish [15]. Considering that plasma levels of
ADAMTS13 have been reported to be decreased in
patients with myocardial infarction [16,17], rs4962153-A
may reduce the plasma ADAMTS13 concentration in
patients with ischemic stroke. Since it seems unlikely
that the transcription level of ADAMTS13 is capable of
being increased and decreased by rs4962153-A depend-
ing on the situation, the detected association of
rs4962153-A may be a false positive in either study. To
examine the present results, the effect of rs4962153 on
the transcription and/or plasma levels of ADAMTS13 in
malaria patients and healthy controls should be investi-
gated in the future.
Since variation screening of the ADAMTS13 gene for
Thai malaria patients was not conducted, the possibility
that the association between rs4962153 and cerebral
malaria detected in the present study has been caused
by LD from the other polymorphisms cannot be
excluded. The analysis of LD based on the HapMap
database revealed that, in the Asian HapMap popula-
tions (JPT + CHB), rs4962153 was in strong LD with
rs739468, rs3124765, and rs3094379 with r
2 of 1, 1, and
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Figure 3 The means and standard errors of platelet counts broken down by rs4962153 genotypes. Comparison among AA, AG, and GG
genotypes at rs4962153 was made using ANCOVA by adjusting for age (years), gender (female or male), and symptom (mild, non-cerebral
severe, or cerebral). No significant difference was detected (P-value = 0.98).
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s o m e9o p e nr e a d i n gf r a m e7( C9orf7) gene, located
adjacent to ADAMTS13. Flower protein, the ortholog of
C9orf7 in Drosophila, has been suggested to function as
aC a
2+ channel to control Ca
2+ influx in insect salivary
gland [18]. The function of human C9orf7 gene remains
to be studied. However, it appears unlikely that poly-
morphism of C9orf7 is primarily associated with cerebral
malaria, since Ca
2+ channel is not currently implicated
in the pathogenesis of cerebral malaria. Since this is the
first study reporting the significant association of
ADAMTS13 polymorphism with cerebral malaria,
further independent studies are required to examine
whether the present finding can be replicated.
Conclusions
PRBCs adhere to the platelet-decorated ULVWF, leading
to enhancement of the sequestration of PRBCs to cere-
bral microvascular endothelium. The platelet-decorated
ULVWF strings are cleaved and regulated by
ADAMTS13. It has been reported that plasma
ADAMTS13 function is significantly reduced in cerebral
malaria patients compared to healthy controls. In this
study, a SNP of ADAMTS13, rs4962153, was found to
be significantly associated with cerebral malaria in 708
Thai patients with P. falciparum malaria. The present
findings support the hypothesis that the regulation of
platelet-decorated ULVWF strings by ADAMTS13 may
play a role in the development of cerebral malaria.
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